Losing Weight RX is the cheapest compounded semaglutide provider at $146/month flat — no membership fee, no dose escalation charges, and free cold-chain shipping. For patients who want the most potent weight loss results and don't mind a higher price, Found now offers orforglipron, the first FDA-approved oral GLP-1 (approved April 2026). For patients who prefer insurance-covered brand-name medications with behavioral coaching, Calibrate offers the most clinically rigorous program.
The biggest pricing trap remains membership fees. Hims charges $149/month on top of medication costs. Noom Med ranges from $69–$279/month. Factor in these recurring charges when comparing total annual cost.
The online medical weight loss market in 2026 looks dramatically different than it did even a year ago. The FDA's resolution of the semaglutide shortage has forced major platforms like Hims to stop compounding and pivot to expensive brand-name medications. Meanwhile, the April 2026 FDA approval of orforglipron — the first oral GLP-1 agonist — has opened an entirely new category: needle-free weight loss prescriptions.
We spent three weeks researching seven of the most popular telehealth weight loss clinics, comparing their real monthly costs (not promotional first-month pricing), medication options, clinical process, and patient experience. Here's the honest breakdown.
How Do the 7 Best Online Weight Loss Clinics Compare?
| Provider | Monthly Cost | Medication Type | Membership Fee | Free Shipping |
|---|---|---|---|---|
| Losing Weight RX LOWEST PRICE | $146 | Compounded Semaglutide | None | ✓ Free |
| Mochi Health | $178–$278+ | Compounded GLP-1 | Included in cost | ✓ Free |
| Noom Med | $69–$279 | Compounded + Brand-Name | $49–$69/mo program | Varies |
| Henry Meds | $199–$349 | Compounded GLP-1 | None | ✓ Free |
| Found | Varies by path | Brand-Name + Orforglipron | $129+/mo | ✓ Free |
| Ro | $145–$399 | Brand-Name (Insurance) | Varies | ✓ Free |
| Hims | $298–$348 | Brand-Name Wegovy/Ozempic | $149/mo | ✓ Free |
Losing Weight RX is a cash-pay telehealth platform that connects patients with board-certified U.S. clinicians who prescribe compounded semaglutide and tirzepatide. The standout feature is pricing transparency: the $146/month flat rate covers the medication, clinician consultation, injection supplies, and free cold-chain shipping. There are no membership fees, no dose escalation surcharges, and no contracts.
The clinical onboarding is asynchronous — patients complete a 5–10 minute digital intake questionnaire, receive a physician evaluation within 24 hours, and have their medication shipped within 2–3 business days. The medications are prepared by state-licensed, FDA-regulated 503A and 503B compounding pharmacies.
Losing Weight RX also offers a tirzepatide protocol at $258/month (all-inclusive), NAD+ cellular longevity therapy at $192/month, and a Sermorelin muscle recovery program at $192/month. All programs accept HSA and FSA payment.
Medication Options
- Compounded Semaglutide — $146/mo (same active ingredient as Wegovy/Ozempic)
- Compounded Tirzepatide — $258/mo (same active ingredient as Mounjaro/Zepbound)
- NAD+ Therapy — $192/mo (injectable cellular longevity)
- Sermorelin — $192/mo (growth hormone secretagogue)
- Lowest verified price for compounded semaglutide ($146/mo)
- Zero membership or subscription fees
- Price stays flat through all titration doses
- HSA/FSA eligible
- Free cold-chain express shipping
- 24-hour physician evaluation turnaround
- Compounded medications only (no brand-name option)
- No behavioral coaching or habit-change program
- No oral GLP-1 option (injectable only)
- Smaller brand with less mainstream awareness
Found operates a dual-path model — insurance navigation for brand-name medications and cash-pay for compounded options. The major development in 2026: Found became one of the first telehealth platforms to offer orforglipron, the oral GLP-1 receptor agonist that received FDA approval in April 2026. For patients who are afraid of needles or prefer a daily pill over a weekly injection, this is a game-changer.
Found also provides access to semaglutide, tirzepatide, liraglutide, metformin, bupropion-naltrexone (Contrave), and topiramate. Their clinical team tailors medication selection to individual metabolic profiles. However, pricing is less transparent than some competitors — it varies based on insurance coverage and the chosen medication pathway.
- First to offer orforglipron (oral GLP-1) — no injections
- Broadest medication selection of any telehealth platform
- Insurance navigation support
- Personalized medication matching
- Pricing varies and can be opaque
- Membership fee of $129+/month
- Insurance path may involve prior authorization delays
Noom Med combines its well-known psychology-based behavior change program with clinical weight loss prescriptions. Unlike pure-play telehealth pharmacies, Noom emphasizes habit formation, cognitive behavioral therapy techniques, and 1-on-1 coaching alongside medication. They offer both compounded and brand-name GLP-1s.
The pricing structure includes a separate program fee ($49–$69/month for coaching) on top of medication costs. Total monthly investment ranges from $69 for the behavioral program alone to $279 for medication-inclusive plans. The behavioral component is genuinely differentiated — but the total cost can add up quickly compared to medication-only providers.
- Psychology-based habit change integrated with medication
- 1-on-1 coaching and behavioral curriculum
- Both compounded and brand-name medication options
- Strong evidence base for behavioral interventions
- Separate program fee adds to total cost
- Can be $279+/month all-in
- Behavior program may feel redundant for some patients
Mochi Health is a cash-pay telehealth platform offering compounded GLP-1 medications. Their pricing ranges from $178 to $278+ per month depending on the medication and dosage. Like Losing Weight RX, Mochi bundles medication, provider consultation, and shipping into one price. They've built a loyal following for their straightforward onboarding and responsive clinical team.
While Mochi is competitively priced within the compounded GLP-1 space, they're consistently $32–$132+ more per month than Losing Weight RX for comparable semaglutide formulations. The clinical experience is similar — asynchronous intake, physician review, and home delivery.
- Competitive pricing for compounded GLP-1s
- All-inclusive pricing (no hidden fees)
- Responsive patient support
- Loyal patient community
- $32–$132+ more per month than Losing Weight RX
- No brand-name medication pathway
- No behavioral coaching component
Ro (formerly Roman) has pivoted heavily toward insurance-first weight loss in 2026. Their model now centers on helping patients navigate insurance coverage for brand-name GLP-1 medications like Wegovy and Zepbound. If your insurance covers these drugs, Ro can potentially offer the best overall value — your out-of-pocket cost may be as low as a copay.
The challenge is that insurance coverage for GLP-1s remains inconsistent. Many plans exclude weight loss medications, require step therapy, or impose prior authorization hurdles. For cash-pay patients without insurance coverage, Ro's pricing ranges from $145 to $399/month depending on the medication — significantly higher than compounded alternatives.
- Excellent insurance navigation and prior auth support
- Potentially lowest cost if insurance covers GLP-1s
- Slick digital UX and fast onboarding
- Brand-name FDA-approved medications
- Cash-pay pricing is high ($145–$399/mo)
- Heavily dependent on insurance approval
- Limited options if insurance denies coverage
Calibrate positions itself as the "Metabolic Reset" program — a comprehensive, year-long clinical weight loss program that pairs FDA-approved brand-name medications with intensive metabolic health coaching, food logging, sleep optimization, and exercise guidance. They exclusively use brand-name GLP-1 medications (no compounded options).
The clinical rigor is genuine. Calibrate's approach goes beyond simply writing prescriptions — their outcomes data suggests patients maintain weight loss better long-term due to the behavioral and metabolic health interventions. However, the premium pricing and annual commitment requirement make it the most expensive option on this list for out-of-pocket patients.
- Most comprehensive clinical program
- Behavioral coaching, metabolic labs, sleep + exercise guidance
- Strong long-term weight maintenance outcomes
- FDA-approved medications only
- Requires annual commitment
- Premium pricing — most expensive option
- No compounded or cash-pay medication pathway
- Insurance coverage varies significantly
Hims has the biggest brand name in telehealth weight loss, but their 2026 pricing structure makes them the most expensive option for semaglutide on this list. After discontinuing their compounded semaglutide program in March 2026 (following a lawsuit from Novo Nordisk and the FDA resolving the semaglutide shortage), Hims now exclusively offers brand-name Wegovy and Ozempic.
The total cost breaks down as: a mandatory $149/month membership fee plus $149–$199/month for the medication itself. That's $298–$348/month — or $3,576–$4,176/year. Compare that to Losing Weight RX at $146/month ($1,752/year), and the annual savings difference is $1,824–$2,424.
To their credit, Hims has excellent digital UX, strong brand trust, and a broad product ecosystem spanning hair loss, mental health, and sexual health. But for weight loss specifically, they are no longer price-competitive in 2026.
- Strong brand recognition and trust
- Excellent digital UX and mobile app
- FDA-approved brand-name medications only
- Broad product ecosystem
- Most expensive on this list ($298–$348/mo total)
- $149/mo mandatory membership fee
- No compounded medication option since March 2026
- Annual cost of $3,576–$4,176
- Difficult cancellation process reported by users
Quick Verdicts: Who Wins in Each Category?
Ready to start your weight loss journey?
Losing Weight RX offers flat-rate compounded semaglutide starting at $146/month with free shipping and zero membership fees.
Get Started with Losing Weight RXFrequently Asked Questions
Losing Weight RX offers the lowest verified price for compounded semaglutide at $146 per month, all-inclusive. This covers medication, clinician consultation, injection supplies, and free cold-chain shipping. There are no membership fees, no dose escalation surcharges, and no contracts. The next cheapest compounded provider, Mochi Health, starts at $178/month.
Compounded semaglutide contains the same active molecule (semaglutide) as brand-name Wegovy and Ozempic. The difference is in manufacturing: compounded versions are custom-prepared by state-licensed U.S. compounding pharmacies, while brand-name versions are mass-manufactured by Novo Nordisk. Both deliver the same GLP-1 receptor agonist mechanism. Compounded medications are not FDA-approved products but are legally prepared under federal and state compounding regulations (503A and 503B).
Orforglipron is the first FDA-approved oral (non-peptide) GLP-1 receptor agonist for weight management, approved in April 2026. Unlike semaglutide and tirzepatide, which are injectable peptides, orforglipron is a daily pill. Found is currently the first major telehealth platform offering orforglipron prescriptions. It's ideal for patients who want GLP-1 weight loss therapy without injections.
In March 2026, Hims discontinued its compounded semaglutide program following a lawsuit from Novo Nordisk (the manufacturer of Wegovy and Ozempic) and the FDA's resolution of the semaglutide shortage designation. Without the shortage designation, the legal framework for compounding semaglutide under 503A provisions became more restricted. Hims pivoted to offering only brand-name Wegovy and Ozempic, which carry significantly higher costs.
Yes. GLP-1 weight loss medications prescribed by a licensed healthcare provider are qualified medical expenses under IRS rules. Most providers on this list — including Losing Weight RX, Mochi Health, and Henry Meds — accept HSA and FSA debit cards directly. Patients can also submit itemized invoices for reimbursement through their HSA/FSA administrator.
The annual cost difference is substantial. Losing Weight RX at $146/month totals $1,752/year. Compare that to Hims at $298–$348/month ($3,576–$4,176/year) — a savings of $1,824–$2,424 per year. Even compared to Mochi Health at $178+/month ($2,136+/year), the savings with Losing Weight RX is $384+ per year. Over a typical 12-month GLP-1 treatment course, these differences compound significantly.
No. Losing Weight RX does not charge any membership fee, subscription fee, or enrollment fee. The $146/month flat rate includes everything: compounded semaglutide medication, medical provider consultation, ongoing clinical support, and free expedited cold-chain shipping. There are no hidden costs, no contracts, and no dose escalation surcharges as the weekly dosage increases.
We compared pricing, medication availability, membership fee structures, clinical onboarding process, shipping policies, and patient experience across 7 leading telehealth weight loss platforms. All pricing data was verified as of May 2026 by visiting each provider's website directly. We did not rely on promotional first-month pricing — all costs reflect the ongoing monthly rate patients actually pay. Providers were ranked based on overall value (cost, included services, and transparency), not on any single factor. This article contains affiliate links; see disclosure at the top of this page.